#!/usr/bin/env python3
"""S0 Final Report — Way4 Thesis Observational Pre-check

Date: 2026-07-05
Plan: WAY4_REALIZE_PLAN_V14
Verification Label: [FALSIFIED] — thesis NOT supported by crystallographic B-factor data

=== EXECUTIVE SUMMARY ===

The Way4 thesis predicts that anti-IDP antibody CDR-H3 should be more flexible
(higher B-factor) than anti-folded antibodies, and CDR-H3 flexibility should
positively correlate with epitope flexibility.

Results from N=33 PDB structures (16 successfully analyzed: 5 anti-IDP + 11 folded
controls) show:
  - IDP CDR-H3 B-factor: 24.69 ± 8.50 (n=5)
  - Folded CDR-H3 B-factor: 35.87 ± 21.69 (n=11)
  - Mann-Whitney U: p=0.827 (two-sided) — NOT significant
  - Spearman r(epitope_disorder, CDR-H3 B-factor) = -0.327, p=0.253 — NOT significant

The data does NOT support the hypothesis. The IDP group actually shows LOWER
B-factors than the folded-antigen group (opposite direction from prediction).

=== CAVEATS ===

1. SMALL SAMPLE: Only 5 anti-IDP antibodies were successfully analyzed.
   The plan required n≥15 IDP + n≥15 folded controls.

2. B-FACTOR NOISE: Crystal B-factors are affected by crystal packing,
   resolution, and refinement — they are a noisy proxy for true flexibility.

3. NO REAL DISORDER PREDICTION: Epitope disorder was computed from AA propensity
   scales, not from IUPred3 or MD-RMSF as specified in the plan.

4. CDR-H3 IDENTIFICATION: Pattern-based CDR-H3 finding is approximate without
   ANARCI antibody numbering. Some CDR-H3 boundaries may be off by 1-3 residues.

5. SEVERAL PDBS EXCLUDED: 6D9B, 7K4V, 5V7V, 7PFE, 6HUV were excluded as
   non-antibody or ambiguous structures. 6H3R and 1YY9 failed CDR-H3 detection.

=== RECOMMENDATION (per V14 plan) ===

S0 VERDICT: NoGo.

Per the plan's iron law: "S0 is the absolute prerequisite — if thesis doesn't
pass, prohibit all model training."

The data suggests the Way4 thesis may not hold at the crystallographic level.
However, given the small sample size, we recommend ONE of the following:

Option A (Plan Compliance): STOP Way4 training immediately. Go to §5 fallback:
  - Template-seeded redesign from 4HIX/5CSZ (Pillar A, 69 variants)
  - Wet-lab screening via phage/yeast display
  - Use disorder/pliability as a SELECTION filter, not a generative driver

Option B (Risk-Aware Extension): Before final NoGo:
  1. Expand sample to n≥15 IDP + n≥15 controls by searching SAbDab/PDB broadly
  2. Run short MD (CDR-H3 only, CPU-based, 5ns) for a subset for true RMSF
  3. Install IUPred3 or use AF2-pLDDT for real disorder prediction
  4. Re-run statistical test with improved metrics

=== FILES PRODUCED ===
  - way4_s0_observational.json  — raw data
  - way4_s0/final_report.py     — this file
  - way4_s0/collect_anti_idp.py — data collection script
  - way4_s0/data/pdbs/          — downloaded PDBs
"""

print(__doc__)
